CBS 2019
CBSMD教育中心
中 文

Other Relevant Articles

Abstract

Recommended Article

Randomized Trial Evaluating Percutaneous Coronary Intervention for the Treatment of Chronic Total Occlusion: The DECISION-CTO Trial Residual Inflammatory Risk in Patients With Low LDL Cholesterol Levels Undergoing Percutaneous Coronary Intervention Cholesterol-Lowering Agents Management of No-Reflow Phenomenon in the Catheterization Laboratory Advances in Coronary No-Reflow Phenomenon-a Contemporary Review Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association Causes of Mortality After Percutaneous Coronary Intervention: Insights From the VA Clinical Assessment, Reporting, and Tracking Program Cardiac Sympathetic Denervation for Refractory Ventricular Arrhythmias

Original Research2016 Jul 19;68(3):313-321.

JOURNAL:J Am Coll Cardiol. Article Link

Management of Patients With NSTE-ACS: A Comparison of the Recent AHA/ACC and ESC Guidelines

Rodriguez F, Mahaffey KW. Keywords: acute coronary syndrome; anticoagulants; antiplatelet; quality of care; risk assessment

FULL TEXT PDF